
Family office investing in emerging companies and offering hands-on help to their founders

Life sciences investment fund concentrating on eye-care and ophthalmic technology opportunities

InFocus Capital Partners invests in life sciences companies that work on eye care. It looks for breakthrough and disruptive opportunities in ophthalmology, then helps to capitalize and develop them. The fund combines practicing eye-care clinicians with experienced venture investors, and the firm says that this mix of medical insight and investment experience is what sets its opportunities apart.
The firm's whole investment strategy is built on ophthalmic innovation. It finds and finances new ideas in eye care, from devices and diagnostics to therapies, Its focus on one specialty is intended to make its judgments more precise.
The founding partners include a practicing ophthalmologist and a venture investor, each with about twenty years of experience in the field. The partners include doctors who lead eye clinics, research programs and academic departments, as well as investors who have worked on venture deals since the early 2000s. Several of them sit on the boards of companies in the portfolio.
The vehicle is InFocus Fund I, a partnership that invests in the ophthalmic opportunities the firm identifies. The firm says its experience, partnership structure and coverage of ophthalmic innovations together give the fund a differentiated opportunity, which it believes improves the odds of successful returns.
Companies in the portfolio include an online vision test, a developer of smart contact lenses and a drug maker for eye disease. These are early and growing businesses developing ophthalmic devices, therapies and diagnostics. Several of the partners sit on the boards of companies in the portfolio.
Physicians from eye clinics, hospitals and universities sit on an advisory panel that the firm draws on. These advisers include leaders of ophthalmology departments and researchers in retina, glaucoma and cornea. The panel informs the firm's choices.
InFocus Capital Partners is a life sciences investment firm whose interest is ophthalmology. It aims to find, fund and develop new ideas in eye care, drawing on partners who are practising clinicians and experienced venture investors.
Early and growing companies working on ophthalmic devices, therapies and diagnostics. Its portfolio news mentions an online vision test, a smart contact lens developer and a drug developer.
Summary written by TrustList from the business's own published information, Nov 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about InFocus Capital Partners.
Similar listings buyers compare against this one.

Family office investing in emerging companies and offering hands-on help to their founders

US law firm advising start-ups, venture capital and growth equity funds and technology companies

Growth fund backed by tech founders, investing in African technology companies as they scale

Seed stage venture capital firm backing US startups with financing, mentoring and marketing consulting

Mid-stage venture firm that backs portfolio companies of established early-stage venture partnerships

Healthcare venture investor backing medical device and biotechnology companies through funding rounds

Corporate venture arm of Rakuten Group investing in start-ups worldwide across fintech, e-commerce, mobility and IT

European venture capital firm backing technology companies from Series A onwards
Everything here links back to the same verified catalogue. Pick your next stop.